Some movement, albeit in the wrong direction. There's now a number of sellers, wanting out in small and large trades. Looks to have been an off market as there hasn't been any buyers in the bid queue wanting that many shares for months.
Previous Shareholder Announcement advised feedback on the BCD would arrive August/September. Sol-M intends to work with MGZ to develop additional products incorporating Medigard's existing IP.
Going on past history it's unlikely there will be feedback to shareholders on the clinical trials, with the next announcement to be another 4C (October), followed by the Chairman's Address to Shareholders soon after (November).
With announcements to the market occurring only when required (or asked) the shedding from holders was inevitable.
I'll be leaving this in the bottom drawer and hope that 10c will reappear.
MGZ Price at posting:
6.0¢ Sentiment: None Disclosure: Held
